ABUS
NASDAQ · Biotechnology
Arbutus Biopharma Corp
$4.55
+0.12 (+2.71%)
Open$4.49
Previous Close$4.43
Day High$4.65
Day Low$4.46
52W High$5.10
52W Low$3.04
Volume—
Avg Volume1.71M
Market Cap898.80M
P/E Ratio5.59
EPS$0.82
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,026.4% upside
Current
$4.55
$4.55
Target
$51.25
$51.25
$34.47
$51.25 avg
$59.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.52M | 20.39M | 146.67M |
| Net Income | -34,529,592 | -43,646,956 | -16,611,843 |
| Profit Margin | -237.9% | -226.0% | -11.3% |
| EBITDA | -38,974,191 | -52,002,080 | -23,689,130 |
| Free Cash Flow | — | — | -19,958,595 |
| Rev Growth | -28.8% | -28.8% | -8.1% |
| Debt/Equity | 0.04 | 0.04 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |